Literature DB >> 6839458

Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients.

H Link, V Kostulas.   

Abstract

Agarose isoelectric focusing was used to demonstrate oligoclonal bands in cerebrospinal fluid (CSF) and serum from 998 consecutive neurological patients. Compared with agarose electrophoresis, agarose isoelectric focusing was slightly more sensitive, showing more (and more easily discernible) oligoclonal bands. Agarose isoelectric focusing, which has good reproducibility, revealed oligoclonal bands in CSF in 95% of 43 patients with multiple sclerosis, 44% of 39 with aseptic meningoencephalitis, and 14% of 906 with other neurological diseases. Interestingly, oligoclonal bands were found in CSF from 12% of 162 patients with acute cerebral infarction and 23% of 53 with polyneuropathy, and also in 29% of 17 with dementia, while only 4% of 206 patients with headache, vertigo, or psychoneurosis had this CSF abnormality. We recommend this procedure for the routine examination of paired CSF and serum specimens for the presence of oligoclonal bands.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6839458

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  18 in total

1.  A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band.

Authors:  Diana Ferraro; Diego Franciotta; Roberta Bedin; Claudio Solaro; Eleonora Cocco; Mario Santangelo; Paolo Immovilli; Alberto Gajofatto; Massimiliano Calabrese; Massimiliano Di Filippo; Riccardo Orlandi; Anna Maria Simone; Francesca Vitetta; Elisabetta Capello; Debora Giunti; Alessandra Murialdo; Jessica Frau; Sara Mariotto; Antongiulio Gallina; Claudio Gasperini; Patrizia Sola
Journal:  J Neurol       Date:  2017-04-05       Impact factor: 4.849

2.  HLA-DR antigen expression on T cells from cerebrospinal fluid in multiple sclerosis and aseptic meningo-encephalitis.

Authors:  S Fredrikson; A Karlsson-Parra; T Olsson; H Link
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

3.  Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system.

Authors:  B N McLean; D Miller; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154

4.  Examinations of cerebrospinal fluid immunoglobulin G by chromatofocusing.

Authors:  P Gallo; A Sidén
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

5.  Elevated cerebrospinal fluid proteins in sciatica caused by disc herniation.

Authors:  J S Skouen; J L Larsen; E Vollset; M Grønning
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

6.  Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis.

Authors:  S Fredrikson; P Eneroth; H Link
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

7.  Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries.

Authors:  I Cortese; R Tafi; L M Grimaldi; G Martino; A Nicosia; R Cortese
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders.

Authors:  O G Segurado; H Krüger; H G Mertens
Journal:  J Neurol       Date:  1986-08       Impact factor: 4.849

9.  Detection of IgG oligoclonal bands in unconcentrated CSF by means of agarose isoelectric focusing, double immunofixation peroxidase staining and avidin-biotin amplification.

Authors:  P Gallo; F Bracco; L Battistin; B Tavolato
Journal:  Ital J Neurol Sci       Date:  1985-09

10.  Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.

Authors:  Steffen Halbgebauer; André Huss; Mathias Buttmann; Petra Steinacker; Patrick Oeckl; Isabel Brecht; Andreas Weishaupt; Hayrettin Tumani; Markus Otto
Journal:  J Neurol       Date:  2016-03-19       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.